Xu C - Search Results

1

CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular Subtypes.

Liu Y, Wu Y, Zhang P, Xu C, Liu Z, He C, Liu Y, Kang Z. Liu Y, et al. Among authors: xu c. Front Oncol. 2021 Mar 4;11:636870. doi: 10.3389/fonc.2021.636870. eCollection 2021. Front Oncol. 2021. PMID: 33747959 Free PMC article.

2

Application of m⁶A and TME in Predicting the Prognosis and Treatment of Clear Cell Renal Cell Carcinoma.

Pei D, Xu C, Wang D, Shi X, Zhang Y, Liu Y, Liu N, Guo J, Yu Y, Kang Z, Zhu H. Pei D, et al. Among authors: xu c. J Oncol. 2022 Mar 4;2022:2910491. doi: 10.1155/2022/2910491. eCollection 2022. J Oncol. 2022. PMID: 35281520 Free PMC article.

3

Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial Carcinoma.

Xu C, Pei D, Liu Y, Yu Y, Guo J, Liu N, Kang Z. Xu C, et al. Front Oncol. 2022 Mar 1;12:818860. doi: 10.3389/fonc.2022.818860. eCollection 2022. Front Oncol. 2022. PMID: 35299749 Free PMC article.

4

A Novel Prognostic Signature Associated With the Tumor Microenvironment in Kidney Renal Clear Cell Carcinoma.

Pei D, Xu C, Wang D, Shi X, Zhang Y, Liu Y, Guo J, Liu N, Zhu H. Pei D, et al. Among authors: xu c. Front Oncol. 2022 Jul 4;12:912155. doi: 10.3389/fonc.2022.912155. eCollection 2022. Front Oncol. 2022. PMID: 35860566 Free PMC article.

5

Clinical M2 Macrophage-Related Genes Can Serve as a Reliable Predictor of Lung Adenocarcinoma.

Xu C, Song L, Yang Y, Liu Y, Pei D, Liu J, Guo J, Liu N, Li X, Liu Y, Li X, Yao L, Kang Z. Xu C, et al. Front Oncol. 2022 Jul 22;12:919899. doi: 10.3389/fonc.2022.919899. eCollection 2022. Front Oncol. 2022. PMID: 35936688 Free PMC article.

6

Clinical Eosinophil-Associated Genes can Serve as a Reliable Predictor of Bladder Urothelial Cancer.

Xu C, Song L, Peng H, Yang Y, Liu Y, Pei D, Guo J, Liu N, Liu J, Li X, Li C, Kang Z. Xu C, et al. Front Mol Biosci. 2022 Jul 22;9:963455. doi: 10.3389/fmolb.2022.963455. eCollection 2022. Front Mol Biosci. 2022. PMID: 35936781 Free PMC article.

7

Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and in vitro validation.

Yu Y, Huang Y, Li C, Ou S, Xu C, Kang Z. Yu Y, et al. Among authors: xu c. Front Genet. 2022 Nov 16;13:1047004. doi: 10.3389/fgene.2022.1047004. eCollection 2022. Front Genet. 2022. PMID: 36468020 Free PMC article.

8

Clinical characteristics and prostate-cancer-specific mortality of competitive risk nomogram in the second primary prostate cancer.

Xu C, Pei D, Liu Y, Guo J, Liu N, Wang Q, Yu Y, Kang Z. Xu C, et al. Front Oncol. 2023 May 16;13:918324. doi: 10.3389/fonc.2023.918324. eCollection 2023. Front Oncol. 2023. PMID: 37260974 Free PMC article.

9

Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation.

Dong Y, Xu C, Su G, Li Y, Yan B, Liu Y, Yin T, Mou S, Mei H. Dong Y, et al. Among authors: xu c. Front Immunol. 2023 May 18;14:1122570. doi: 10.3389/fimmu.2023.1122570. eCollection 2023. Front Immunol. 2023. PMID: 37275895 Free PMC article.

10

Development and validation of a competing risk model for second primary pancreatic ductal adenocarcinoma: A population-based study.

Song L, Xu C, Zhang T, Chen S, Shi Z, Hu S, Cheng B, Tong H, Wei G, Li X. Song L, et al. Among authors: xu c. Front Surg. 2022 Aug 30;9:934148. doi: 10.3389/fsurg.2022.934148. eCollection 2022. Front Surg. 2022. PMID: 36111234 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,114 results

Search Page

Filters